Company:  AMNEAL PHARMACEUTICALS, I ... (AMRX)
Form Type:  SC 13G/A
Filing Date:  2/12/2020 
CIK:  0001723128 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$4.79  
Change: 
0.09 (1.92%)  
Trade Time: 
Jun 03  
Market Cap: 
$705.64M
Trade AMRX now with 

© 2020  
Description of Business
Amneal Pharmaceuticals, Inc. (the "Company," "we," "us," or "our"), together with its subsidiaries, is a global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products in a variety of dosage forms and therapeutic categories. The Company is a Delaware corporation and was formed under the name Atlas Holdings, Inc. on October 4, 2017, for the purpose of facilitating the combination (the "Combination") of Amneal Pharmaceuticals LLC ("Amneal"), a Delaware limited liability company, and Impax Laboratories, Inc. ("Impax"), a Delaware corporation. Prior to the Combination, Amneal was a privately held limited liability company with a portfolio of generic pharmaceutical products and Impax was a publicly held corporation with a portfolio of generic and specialty pharmaceutical products. On May 4, 2018, the Combination was completed and the Company changed its name from Atlas Holdings, Inc.
Register and access this filing in:     
  FORM SC 13G/A